Literature DB >> 2662323

Aerobic exercise during pregnancy. Special considerations.

S P Sady1, M W Carpenter.   

Abstract

Alterations in maternal physiology during pregnancy affect the physiological respect to aerobic exercise. Maternal resting oxygen consumption (VO2) and cardiac output increase during pregnancy. Heart rate (HR) becomes progressively elevated through gestation, whereas stroke volume (SV) increases until the third trimester and then declines until term, probably because of diminished venous return. Plasma volume increases earlier and to a greater magnitude than red cell volume, resulting in the 'haemodilutional anaemia' of pregnancy and a decline in the oxygen-carrying capacity. Ventilation is greater during pregnancy because of elevated tidal volume and unchanged rate of breathing. The acute and chronic (training) responses to aerobic exercise during pregnancy have not been thoroughly investigated. Specifically, the effect of gestational age, maternal activity status, and type, duration and intensity of exercise on maternal cardiovascular response have only recently begun to be explored. During pregnancy cardiac output during submaximal exertion increases above values in non-pregnant women, except perhaps late in gestation. Both heart rate and stroke volume contribute to the elevated cardiac output. Changes in submaximal exercise VO2 during pregnancy are dependent on the mode of exercise. At the same workload, VO2 increases during weight-bearing exercise, but usually does not differ from postpartum values during weight-supported exercise. One study found no change in VO2max during pregnancy compared to postpartum values. Some recent evidence indicates that the cardiac output vs VO2 relationship for pregnant women is within the range of average values reported for non-pregnant individuals. Exercise arterial-venous oxygen difference is lower during pregnancy, suggesting that the higher cardiac output is distributed to non-exercising vascular beds. The data are limited but suggest that the perfusion of exercising muscle is unchanged during pregnancy and that the major haemodynamic change is an augmented cardiac output so that blood flow to the uterus and fetus is not compromised. Only one study has measured blood flow during exercise in pregnant women. The reported 25% decrease in uterine blood flow during supine cycle exercise in women late in gestation must be interpreted cautiously because the uterus may obstruct the vena cava in the supine position. Studies of exercising pregnant animals usually indicate a decreased uterine blood flow but an enhanced oxygen extraction; the lower blood flow may be limited to non-placental areas. The applicability of these results to humans is unknown.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Year:  1989        PMID: 2662323     DOI: 10.2165/00007256-198907060-00002

Source DB:  PubMed          Journal:  Sports Med        ISSN: 0112-1642            Impact factor:   11.136


  73 in total

1.  The oxygen cost of breathing in dyspnoeic subjects as studied in normal pregnant women.

Authors:  R A BADER; M E BADER; D J ROSE
Journal:  Clin Sci       Date:  1959-05       Impact factor: 6.124

2.  The effect of pregnancy on metabolic responses during rest, immersion, and aerobic exercise in the water.

Authors:  R G McMurray; V L Katz; M J Berry; R C Cefalo
Journal:  Am J Obstet Gynecol       Date:  1988-03       Impact factor: 8.661

3.  Questions and Answers: ACSM 1985.

Authors:  F Caldwell; T Jopke
Journal:  Phys Sportsmed       Date:  1985-08       Impact factor: 2.241

4.  Cardiovascular dynamics in women receiving oral contraceptive therapy.

Authors:  W A Walters; Y L Lim
Journal:  Lancet       Date:  1969-10-25       Impact factor: 79.321

5.  Effect of exercise stress on carotid, uterine, and iliac blood flow in pregnant and nonpregnant ewes.

Authors:  J Orr; T Ungerer; J Will; K Wernicke; L B Curet
Journal:  Am J Obstet Gynecol       Date:  1972-09-15       Impact factor: 8.661

6.  Olympic participation by women. Effects on pregnancy and childbirth.

Authors:  E Zaharieva
Journal:  JAMA       Date:  1972-08-28       Impact factor: 56.272

7.  Cardiorespiratory response to exercise during pregnancy.

Authors:  C A Guzman; R Caplan
Journal:  Am J Obstet Gynecol       Date:  1970-10-15       Impact factor: 8.661

8.  Cardiorespiratory fitness during pregnancy and its effect on outcome.

Authors:  S C Wong; D C McKenzie
Journal:  Int J Sports Med       Date:  1987-04       Impact factor: 3.118

9.  Acute exercise stress in the pregnant ewe.

Authors:  J F Clapp
Journal:  Am J Obstet Gynecol       Date:  1980-02-15       Impact factor: 8.661

Review 10.  The interactions of exercise and pregnancy: a review.

Authors:  F K Lotgering; R D Gilbert; L D Longo
Journal:  Am J Obstet Gynecol       Date:  1984-07-01       Impact factor: 8.661

View more
  5 in total

1.  Maternal rectal temperature and fetal heart rate responses to upright cycling in late pregnancy.

Authors:  M E O'Neill
Journal:  Br J Sports Med       Date:  1996-03       Impact factor: 13.800

Review 2.  Physical activity and pregnancy outcome. Review and recommendations.

Authors:  B Sternfeld
Journal:  Sports Med       Date:  1997-01       Impact factor: 11.928

3.  Resistance Training Does Not Decrease Placental Blood Flow During Valsalva Maneuver: A Novel Use of 3D Doppler Power Flow Ultrasonography.

Authors:  Sara Gould; Chase Cawyer; Louis Dell'Italia; Lorie Harper; Gerald McGwin; Marcas Bamman
Journal:  Sports Health       Date:  2021-03-12       Impact factor: 3.843

4.  Maximizing Recovery in the Postpartum Period: A Timeline for Rehabilitation from Pregnancy through Return to Sport.

Authors:  Rachel Selman; Kate Early; Brianna Battles; Misty Seidenburg; Elizabeth Wendel; Susan Westerlund
Journal:  Int J Sports Phys Ther       Date:  2022-10-01

5.  Water aerobics II: maternal body composition and perinatal outcomes after a program for low risk pregnant women.

Authors:  Sergio R Cavalcante; Jose G Cecatti; Rosa I Pereira; Erica P Baciuk; Ana L Bernardo; Carla Silveira
Journal:  Reprod Health       Date:  2009-01-06       Impact factor: 3.223

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.